![](/img/cover-not-exists.png)
Rosiglitazone sensitizes MDA-MB-231 breast cancer cells to anti-tumour effects of tumour necrosis factor- , CH11 and CYC202
Mody, M., Dharker, N., Bloomston, M., Wang, P.-S., Chou, F.-S., Glickman, T. S, McCaffrey, T., Yang, Z., Pumfery, A., Lee, D., Ringel, M. D, Pinzone, J. JVolume:
14
Language:
english
Journal:
Endocrine Related Cancer
DOI:
10.1677/ERC-06-0003
Date:
June, 2007
File:
PDF, 272 KB
english, 2007